Current understanding of primary biliary cholangitis
Atsushi Tanaka
Clin Mol Hepatol. 2021;27(1):1-21.   Published online 2020 Dec 3     DOI: https://doi.org/10.3350/cmh.2020.0028
Citations to this article as recorded by Crossref logo
Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology
Yuanyuan Li, Xiaotian Peng, Guofeng Wang, Bin Zan, Yahang Wang, Juan Zou, Tian Tian, Qian Meng, Rong Shi, Tianming Wang, Jiasheng Wu, Yueming Ma
Journal of Ethnopharmacology.2024; 319: 117060.     CrossRef
Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
Miaochan Wang, Yujiao Jin, Aifang Xu
Clinical Chemistry and Laboratory Medicine (CCLM).2024; 62(2): e53.     CrossRef
Autotaxin: A Potential biomarker for primary biliary cholangitis
Yifei Yang, Bingqian Liu, Bo Zang, Qixuan Liu, Chenyang Zhao, Yuan Yao, Bin Liu
Heliyon.2024; 10(1): e23438.     CrossRef
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center
Seyed Erfan Mehdi Nejad, Mohammad Heiat, Mohammad Javanbakht, Seyed Moayed Alavian, Mohammad Ali Abyazi Haris
BMC Gastroenterology.2024;[Epub]     CrossRef
Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines
Matteo Biagi, Elisa Bernasconi, Carmela Cursaro, Enrico Ronconi, Filippo Zanni, Pamela Sighinolfi, Pietro Andreone
Exploration of Drug Science.2024; : 1.     CrossRef
Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study
Zhekang Liu, Yijia Shao, Xinwang Duan, Alessandro Granito
PLOS ONE.2024; 19(2): e0298225.     CrossRef
Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma
Annarosa Floreani, Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences.2024; 25(4): 2194.     CrossRef
Reasons why women are more likely to develop primary biliary cholangitis
Di Ma, Jiaxuan Ma, Chunmei Zhao, Wenlin Tai
Heliyon.2024; 10(4): e25634.     CrossRef
Autoimmune hepatitis-primary biliary cholangitis overlap syndrome complicated by various autoimmune diseases: A case report
Yu-Jie Qin, Ting Gao, Xing-Nian Zhou, Ming-Liang Cheng, Hong Li
World Journal of Clinical Cases.2024; 12(6): 1174.     CrossRef
Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review
Salma Souissi, Sarah Laabidi, Nadia Ben Mustpha, Ines Chelly, Meriem Serghini, Monia Fekih, Asma Laabidi, Jalel Boubaker
Future Science OA.2024;[Epub]     CrossRef
Autoimmune Liver Disease Associated Uveitis: An Extrahepatic Manifestation or a Polyautoimmunity Phenomenon? Case Reports
Laura Zarate-Pinzón, Gabriela Flórez-Esparza, Camilo Andrés Rodríguez-Rodríguez, Luis A. Diez-Bahamón, Germán Mejía-Salgado, Carlos Cifuentes-González, Alejandra de-la-Torre
Ocular Immunology and Inflammation.2024; : 1.     CrossRef
Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis
Yazhen Zhang, Yujiao Jin, Yuan Liu, Miaochan Wang, Aifang Xu
Clinical Chemistry and Laboratory Medicine (CCLM).2024;[Epub]     CrossRef
Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk
Yan Liang, Jie Li, Zhiyu Zhang, Tingwang Jiang, Zaixing Yang
Clinics and Research in Hepatology and Gastroenterology.2024; 48(5): 102321.     CrossRef
JCAD, a new potential therapeutic target in cholestatic liver disease
Byoung Kuk Jang
Clinical and Molecular Hepatology.2024; 30(2): 166.     CrossRef
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy
Isa Seida, Maisam Al Shawaf, Naim Mahroum
Autoimmunity Reviews.2024; : 103541.     CrossRef
Are Gender Differences Important for Autoimmune Liver Diseases?
Annarosa Floreani, Daniela Gabbia, Sara De Martin
Life.2024; 14(4): 500.     CrossRef
Associations between residential volatile organic compound exposures and liver injury markers: The role of biological sex and race
Banrida Wahlang, Hong Gao, Shesh N. Rai, Rachel J. Keith, Craig J. McClain, Sanjay Srivastava, Mathew C. Cave, Aruni Bhatnagar
Environmental Research.2023; 221: 115228.     CrossRef
Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clinical and Molecular Hepatology.2023; 29(1): 194.     CrossRef
Evalucation of differences in clinical and laboratory parameters in the combination of primary biliary cholangitis and associated diseases
B. A. Abilbekova, A. Zh. Satmetova
Experimental and Clinical Gastroenterology.2023; (8): 70.     CrossRef
Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach
Nutrients.2023; 15(3): 760.     CrossRef
Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation
Huiwen Wang, Jian Zhang, Jinqing Liu, Yongfang Jiang, Lei Fu, Shifang Peng
Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
Clinical Characteristics of Patients with Primary Biliary Cholangitis Complicated with Sjogren’s Syndrome
晨阳 赵
Advances in Clinical Medicine.2023; 13(02): 2690.     CrossRef
Japanese subgroup analysis of GLIMMER: A global Phase IIb study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis
Atsushi Tanaka, Masanori Atsukawa, Keiji Tsuji, Kazuo Notsumata, Akari Suyama, Hiroshi Ito, Sugato Das, Robyn von Maltzahn, Megan M. McLaughlin
Hepatology Research.2023; 53(7): 629.     CrossRef
Diabetic Mastopathy With an Associated History of Elevated Thyroid Peroxidase (TPO) and Antimitochondrial Antibodies (AMA)
Shreyan A Patel, Saba Naamo, Liping Li, Tatianie Jackson
Cureus.2023;[Epub]     CrossRef
The impact of recipient and donor gender-match and mismatch on the post-liver transplant outcomes of patients with primary biliary cholangitis
David Uihwan Lee, Reid Ponder, Sarah Sandlow, Ashley Yoo, Ki Jung Lee, Harrison Chou, Gregory Hongyuan Fan, Nathalie Helen Urrunaga
Digestive and Liver Disease.2023; 55(9): 1242.     CrossRef
Characteristic geoepidemiology of primary biliary cholangitis in Taiwan: A nationwide population‐based study
Jur‐Shan Cheng, Wei‐Ting Chen, Hsin‐Ping Ku, Rong‐Nan Chien, Ming‐Ling Chang
Hepatology Research.2023; 53(9): 866.     CrossRef
Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019
Kyung-Ah Kim, Hwa Young Choi, Moran Ki, Eun Sun Jang, Sook-Hyang Jeong
Journal of Gastroenterology.2023; 58(7): 682.     CrossRef
An Unexpected Association of Primary Biliary Cholangitis in a Male Patient With Autosomal Dominant Polycystic Kidney Disease
Patricio A Jaramillo, Sabina Ibrahimli, Javier Castells
Cureus.2023;[Epub]     CrossRef
Serological markers of rheumatoid arthritis in patients with primary biliary cholangitis and the vice versa: A Tunisian study
Mariam Ghozzi, Amani Mankai, Inssaf Zneidi, Wiem Manoubi, Sarra Melayah, Fatma Mechi, Abdelhalim Trabelsi, Ibtissem Ghedira
Immunobiology.2023; 228(4): 152398.     CrossRef
Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
Aalam Sohal, Kris V Kowdley
Hepatic Medicine: Evidence and Research.2023; Volume 15: 63.     CrossRef
Primary biliary cholangitis: Epidemiology, prognosis, and treatment
Juan Trivella, Binu V. John, Cynthia Levy
Hepatology Communications.2023;[Epub]     CrossRef
Immunological factors in cirrhosis diseases from a bibliometric point of view
Dan Zhang, Bo-Wen Liu, Xiao-Qing Liang, Fu-Quan Liu
World Journal of Gastroenterology.2023; 29(24): 3899.     CrossRef
Causal associations between inflammatory bowel disease and primary biliary cholangitis: a two-sample bidirectional Mendelian randomization study
Jiaxi Zhao, Kaixin Li, Xiaoyang Liao, Qian Zhao
Scientific Reports.2023;[Epub]     CrossRef
Magnetic resonance imaging findings of the lower limb muscles in anti-mitochondrial M2 antibody-positive myositis
Hirotaka Nomiya, Tadanori Hamano, Naoko Takaku, Hirohito Sasaki, Kojiro Usui, Sayaka Sanada, Tomohisa Yamaguchi, Yuki Kitazaki, Yoshinori Endo, Tomoko Kamisawa, Soichi Enomoto, Norimichi Shirafuji, Akiko Matsunaga, Asako Ueno, Masamichi Ikawa, Osamu Yamam
Neuromuscular Disorders.2023; 33(9): 74.     CrossRef
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect
Annarosa Floreani, Daniela Gabbia, Sara De Martin
Expert Review of Gastroenterology & Hepatology.2023; 17(9): 863.     CrossRef
Management of adults with Alagille syndrome
Mohammed D. Ayoub, Ahmad A. Bakhsh, Shannon M. Vandriel, Verena Keitel, Binita M. Kamath
Hepatology International.2023; 17(5): 1098.     CrossRef
Advances in clinical detection methods and nanomaterials for autoimmune liver diseases
Jingjing Chen, Yaqi Zhu, Qingcui Wang, Jinya Ding, Xiaohua Chen
Nano TransMed.2023; 2(2-3): 100003.     CrossRef
Estrogen receptor alpha‐mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis
Mengting Liang, Siwen Ye, Rubin Jing, Bukun Zhu, Wenjie Yuan, Xi Chu, Ying Li, Wei Zhang
Environmental Toxicology.2023; 38(12): 2803.     CrossRef
The feasibility and acceptability of an online mind-body wellness program for patients with primary biliary cholangitis
Makayla Watt, Ashley Hyde, John C Spence, Gail M Wright, Shauna Vander Well, Emily Johnson, Andrew Mason, Magnus McLeod, Puneeta Tandon
Canadian Liver Journal.2023; 6(3): 314.     CrossRef
Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets
Alina Grama, Alexandra Mititelu, Claudia Sîrbe, Gabriel Benţa, Tudor Lucian Pop
Frontiers in Immunology.2023;[Epub]     CrossRef
Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
Yujiao Jin, Miaochan Wang, Yuan Liu, Aifang Xu
Medicine.2023; 102(42): e35617.     CrossRef
Detection of Lymphadenopathy as a Precursor to Autoimmune Liver Diseases Before Clinical Hepatitis Became Apparent: A Report of Two Cases
Hiroshi Okano, Hiroki Tanaka, Shimpei Matsusaki, Katsumi Mukai, Akira Nishimura, Kana Asakawa, Youichirou Baba, Tetsuya Murata
Cureus.2023;[Epub]     CrossRef
Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
Hyejung Jang, Nayoung Han, Christine E. Staatz, Jae-Hwan Kwak, In-hwan Baek
Clinics and Research in Hepatology and Gastroenterology.2023; 47(10): 102227.     CrossRef
Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients
Xi Su, Wenwen Jin, Lizhi Liu, Zifei Zhu, Cunyan Li
Frontiers in Immunology.2023;[Epub]     CrossRef
Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review
Hong-Jin Chen, Ting-Xiong Huang, Yu-Xi Jiang, Xiong Chen, Ai-Fang Wang
World Journal of Hepatology.2023; 15(12): 1258.     CrossRef
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yao Yang, Jinjung Choi, Ying Chen, Pietro Invernizzi, Guoxiang Yang, Weici Zhang, Ti‐hong Shao, Frank Jordan, Natalia S. Nemeria, Ross L. Coppel, William M. Ridgway, Mark Kurth, Aftab A. Ansari, Patrick S.C. Leung, M. Eric Gershwin
Hepatology.2022; 75(2): 266.     CrossRef
Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid
Weijia Han, Chunyang Huang, Qi Zhang, Shuhui Tao, Xiaomin Hu, Jianguo Xu, Ronglong Jiang, Bin Xu, Yanmin Liu, Jinlin Hou
European Journal of Clinical Investigation.2022;[Epub]     CrossRef
Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study
Guillermo Muñoz-Sánchez, Albert Pérez-Isidro, Iñaki Ortiz de Landazuri, Antonio López-Gómez, Luz Yadira Bravo-Gallego, Milagros Garcia-Ormaechea, Maria Rosa Julià, Odette Viñas, Estíbaliz Ruiz-Ortiz
Diagnostics.2022; 12(3): 697.     CrossRef
Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino
The American Journal of the Medical Sciences.2022; 364(3): 359.     CrossRef
Primary Biliary Cholangitis
Andrew R. Scheinberg, Cynthia Levy
Current Treatment Options in Gastroenterology.2022; 20(3): 469.     CrossRef
Terapias usuales y emergentes en colangitis biliar primaria
Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez
Hepatología.2022; : 155.     CrossRef
Hiperbilirrubinemia: visión del patólogo
Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio
Hepatología.2022; : 176.     CrossRef
Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Sung Hak Lee, Pil Soo Sung
Journal of Hepatology.2022; 77(4): 1209.     CrossRef
Loperamide induces excessive accumulation of bile acids in the liver of mice with different diets
Zili Lei, Hedong Rong, Yanhong Yang, Siping Yu, Tianle Zhang, Lei Chen, Ya Nie, Qi Song, Qing Hu, Jiao Guo
Toxicology.2022; 477: 153278.     CrossRef
Endothelin receptor B enhances liver injury and pro-inflammatory responses by increasing G-protein-coupled receptor kinase-2 expression in primary biliary cholangitis
Guoxin Xu, Yanping Gong, Fenying Lu, Bin Wang, Zaixing Yang, Long Chen, Jingyu Min, Cuie Cheng, Tingwang Jiang
Scientific Reports.2022;[Epub]     CrossRef
Clinical and Pathological Research Progress of Common Autoimmune Liver Diseases
良玉 丁
Advances in Clinical Medicine.2022; 12(10): 8983.     CrossRef
Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review
Liuting Zeng, Kailin Yang, Tianqing Zhang, Xiaofei Zhu, Wensa Hao, Hua Chen, Jinwen Ge
Journal of Autoimmunity.2022; 133: 102919.     CrossRef
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
Clinical and Molecular Hepatology.2022; 28(4): 926.     CrossRef
Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis
Hong-Li Liu, An-Yin Yang, Qing-Fang Xiong, Yan-Dan Zhong, Du-Xian Liu, Ping Huang, Xiao-Ning Feng, Yu Zhang, Yong-Feng Yang
BMC Gastroenterology.2022;[Epub]     CrossRef
Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis
Vasiliy I. Reshetnyak, Igor V. Maev
Biomedicines.2022; 10(12): 3046.     CrossRef
Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: A mendelian randomization study
Honglin Xu, Ziyan Wu, Futai Feng, Yongzhe Li, Shulan Zhang
Frontiers in Immunology.2022;[Epub]     CrossRef
The Gut-Liver Axis in Cholestatic Liver Diseases
Andreas Blesl, Vanessa Stadlbauer
Nutrients.2021; 13(3): 1018.     CrossRef
Clinical and serological prognostic markers in primary biliary cholangitis
Markus Wilhelmi
Clinical and Molecular Hepatology.2021; 27(2): 360.     CrossRef